A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study

Upper gastrointestinal (GI) side effects are a main reason for discontinuing bisphosphonate treatment, an important therapeutic option for osteoporosis patients. Consequently, the development of novel formulations with improved tolerability is warranted. In this multicenter prospective, observationa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JBMR Plus
Glavni autori: Minisola, Salvatore, Vargas, Antonio P, Letizia Mauro, Giulia, Bonet Madurga, Fernando, Adami, Giovanni, Black, Dennis M, Qizilbash, Nawab, Blanch‐Rubió, Josep
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2021
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260812/
https://ncbi.nlm.nih.gov/pubmed/34258506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10510
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items